These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9545557)

  • 21. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects.
    Alarayyed NA; Graham BR; Prichard BN; Smith CC
    Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective inhibitory effects of chlorpromazine and imipramine on platelet aggregation.
    Ishigooka J; Tanaka K; Suzuki Y; Katori M; Miura S
    Int Pharmacopsychiatry; 1980; 15(5):270-80. PubMed ID: 7263149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of platelet function by polymorphonuclear leukocytes.
    Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
    J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP-mimicking platelet aggregation caused by rugosin E, an ellagitannin isolated from Rosa rugosa Thunb.
    Teng CM; Kang YF; Chang YL; Ko FN; Yang SC; Hsu FL
    Thromb Haemost; 1997 Mar; 77(3):555-61. PubMed ID: 9066010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H
    Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation on the antiplatelet activity of pyrrolo[3,2-c]pyridine-containing compounds.
    Voskressensky LG; de Candia M; Carotti A; Borisova TN; Kulikova LN; Varlamov AV; Altomare C
    J Pharm Pharmacol; 2003 Mar; 55(3):323-32. PubMed ID: 12724037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diazepam and clonazepam on the function of isolated rat platelet and neutrophil.
    Rajtar G; Zółkowska D; Kleinrok Z
    Med Sci Monit; 2002 Apr; 8(4):PI37-44. PubMed ID: 11951080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
    Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
    Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet actions of aporphinoids from Formosan plants.
    Chia YC; Chen KS; Chang YL; Teng CM; Wu YC
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3295-300. PubMed ID: 10612588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-platelet aggregation constituents from Gynura elliptica.
    Lin WY; Teng CM; Tsai IL; Chen IS
    Phytochemistry; 2000 Apr; 53(8):833-6. PubMed ID: 10820787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential inhibition of human neutrophil activation by cyclosporins A, D, and H. Cyclosporin H is a potent and effective inhibitor of formyl peptide-induced superoxide formation.
    Wenzel-Seifert K; Grünbaum L; Seifert R
    J Immunol; 1991 Sep; 147(6):1940-6. PubMed ID: 1653806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng.
    Teng CM; Kuo SC; Ko FN; Lee JC; Lee LG; Chen SC; Huang TF
    Biochim Biophys Acta; 1989 Mar; 990(3):315-20. PubMed ID: 2923911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two new arylnaphthalide lignans and antiplatelet constituents from Justicia procumbens.
    Weng JR; Ko HH; Yeh TL; Lin HC; Lin CN
    Arch Pharm (Weinheim); 2004 Apr; 337(4):207-12. PubMed ID: 15065080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.